Suppr超能文献

对于已经接受最佳药物治疗的急性冠脉综合征或稳定型心绞痛的糖尿病患者,冠状动脉血运重建是否有额外获益?

Is there an additional benefit from coronary revascularization in diabetic patients with acute coronary syndromes or stable angina who are already on optimal medical treatment?

机构信息

2 Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippocration Hospital, Thessaloniki, Greece.

出版信息

Arch Med Sci. 2011 Dec 31;7(6):1067-75. doi: 10.5114/aoms.2011.26621. Epub 2011 Dec 30.

Abstract

Cardiovascular disease (CVD) is common in patients with diabetes mellitus (DM) and related clinical outcomes are worse compared with non-diabetics. The optimal treatment in diabetic patients with coronary heart disease (CHD) is currently not established. We searched MEDLINE (1975-2010) using the key terms diabetes mellitus, coronary heart disease, revascularization, coronary artery bypass, angioplasty, coronary intervention and medical treatment. Most studies comparing different revascularization procedures in patients with CHD favoured coronary artery bypass graft (CABG) surgery in patients with DM. However, most of this evidence comes from subgroup analyses. Recent evidence suggests that advanced percutaneous coronary intervention (PCI) techniques along with best medical treatment may be non-inferior and more cost-effective compared with CABG. Treatment of vascular risk factors is a key option in terms of improving CVD outcomes in diabetic patients with CHD. The choice between medical therapy and revascularization warrants further assessment.

摘要

心血管疾病(CVD)在糖尿病(DM)患者中很常见,与非糖尿病患者相比,其临床预后更差。目前,对于患有冠心病(CHD)的糖尿病患者,最佳治疗方法尚未确定。我们使用糖尿病、冠心病、血运重建、冠状动脉旁路移植术、血管成形术、冠状动脉介入治疗和药物治疗等关键词在 MEDLINE(1975-2010 年)进行了检索。大多数比较不同血运重建程序在 CHD 患者中的研究结果都倾向于在 DM 患者中采用冠状动脉旁路移植术(CABG)。然而,这些证据大多来自亚组分析。最近的证据表明,与 CABG 相比,先进的经皮冠状动脉介入治疗(PCI)技术联合最佳药物治疗可能具有非劣效性和更高的成本效益。治疗血管危险因素是改善 CHD 合并糖尿病患者 CVD 结局的关键选择。药物治疗与血运重建之间的选择需要进一步评估。

相似文献

2
Diabetes and coronary revascularization.糖尿病与冠状动脉血运重建
JAMA. 2005 Mar 23;293(12):1501-8. doi: 10.1001/jama.293.12.1501.

引用本文的文献

1
Management of Chronic Total Occlusion of Coronary Artery.冠状动脉慢性完全闭塞病变的管理
Int J Angiol. 2021 Mar;30(1):48-52. doi: 10.1055/s-0040-1721478. Epub 2020 Dec 3.
5
α-Glucosidase inhibitors and their use in clinical practice.α-葡萄糖苷酶抑制剂及其在临床实践中的应用。
Arch Med Sci. 2012 Nov 9;8(5):899-906. doi: 10.5114/aoms.2012.31621. Epub 2012 Nov 7.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验